Organ-on-Chip Recapitulates Thrombosis Induced by an anti-CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems

Clinical Pharmacology and Therapeutics
R BarrileM A Otieno

Abstract

Clinical development of Hu5c8, a monoclonal antibody against CD40L intended for treatment of autoimmune disorders, was terminated due to unexpected thrombotic complications. These life-threatening side effects were not discovered during preclinical testing due to the lack of predictive models. In the present study, we describe the development of a microengineered system lined by human endothelium perfused with human whole blood, a "Vessel-Chip." The Vessel-Chip allowed us to evaluate key parameters in thrombosis, such as endothelial activation, platelet adhesion, platelet aggregation, fibrin clot formation, and thrombin anti-thrombin complexes in the Chip-effluent in response to Hu5c8 in the presence of soluble CD40L. Importantly, the observed prothrombotic effects were not observed with Hu5c8-IgG2σ designed with an Fc domain that does not bind the FcγRIIa receptor, suggesting that this approach may have a low potential risk for thrombosis. Our results demonstrate the translational potential of Organs-on-Chips, as advanced microengineered systems to better predict human response.

References

Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·A D KirkS J Knechtle
Aug 18, 1997·The American Journal of Cardiology·D R Phillips, R M Scarborough
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·N S KenyonC Ricordi
Oct 8, 1999·The Journal of Clinical Investigation·K KatoT J Kipps
Jul 13, 2002·Arthritis and Rheumatism·Weiqing HuangAnne Davidson
Sep 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Dougald M MonroeHarold R Roberts
Aug 13, 2003·Current Opinion in Hematology·K S Srinivasa PrasadDavid R Phillips
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·K S Srinivasa PrasadDavid R Phillips
Mar 30, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Stamatis-Nick C Liossis, Petros P Sfikakis
Jul 10, 2004·Clinical and Diagnostic Laboratory Immunology·Dimitris DaoussisStamatis-Nick C Liossis
Apr 15, 2005·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Kei KimuraShigeto Kobayashi
Jun 22, 2005·Thrombosis and Haemostasis·Florian LangerJohn L Francis
Oct 31, 2008·Cell and Tissue Research·Nathaniel G dela Paz, Patricia A D'Amore
Jul 15, 2009·Seminars in Immunology·Anna L PetersGail A Bishop
Apr 24, 2010·Nature Reviews. Immunology·Andrew C Chan, Paul J Carter
Jun 26, 2010·Science·Dongeun HuhDonald E Ingber
Jun 30, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Liza Robles-CarrilloAli Amirkhosravi
Jan 21, 2011·Current Pharmaceutical Design·Christoph E Hagemeyer, Karlheinz Peter
Nov 9, 2012·Science Translational Medicine·Dongeun HuhDonald E Ingber
Jan 5, 2013·Proceedings of the National Academy of Sciences of the United States of America·Erik WesteinJohan W M Heemskerk
Jul 23, 2013·Methods : a Companion to Methods in Enzymology·Omid VafaWilliam R Strohl
Mar 29, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jenny H XieAnish Suri
Aug 6, 2014·Nature Biotechnology·Sangeeta N Bhatia, Donald E Ingber
Oct 21, 2015·BMC Cardiovascular Disorders·Jonathan W YauSubodh Verma
Jan 1, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Damir SimicMonicah Otieno
Jul 29, 2016·Biomedical Microdevices·Abhishek JainDonald E Ingber
Aug 27, 2016·Scientific Reports·Janette Bester, Etheresia Pretorius
May 19, 2017·Clinical Pharmacology and Therapeutics·A JainD E Ingber

❮ Previous
Next ❯

Citations

Mar 12, 2019·Current Pharmaceutical Design·Yasamin A JodatSu R Shin
Sep 15, 2018·Journal of Biological Engineering·Jose YesteRosa Villa
Nov 24, 2019·Clinical Pharmacology and Therapeutics·Richard W PeckGeraldine A Hamilton
Jan 23, 2020·Lab on a Chip·Norman C PetersonMatteo Di Piazza
Jan 22, 2020·Annual Review of Analytical Chemistry·Olivier T GuenatFrançois Berthiaume
May 20, 2018·Development·Donald E Ingber
Dec 7, 2018·Lab on a Chip·Albert van den BergAndries D van der Meer
Jan 17, 2019·Nature Reviews. Cancer·Alexandra Sontheimer-PhelpsDonald E Ingber
Sep 12, 2020·Nature Reviews. Drug Discovery·Lucie A LowDanilo A Tagle
Nov 9, 2018·Journal of Translational Medicine·Pandora Pound, Merel Ritskes-Hoitinga
May 31, 2020·Archives of Pharmacal Research·Nileshkumar MeghaniKyung Hyun Choi
Mar 27, 2020·Frontiers in Molecular Biosciences·Caleb Jensen, Yong Teng
Dec 28, 2019·Micromachines·Christopher A HeshWilbur A Lam
Nov 6, 2020·Small·Izmarie Poventud-FuentesDongeun Huh
Jan 29, 2021·Lab on a Chip·Vahid HosseiniAli Khademhosseini
Sep 1, 2019·Nature Reviews. Materials·Michael J KratochvilSarah C Heilshorn
Mar 18, 2021·Cardiovascular Research·Valentina PaloschiLars Maegdefessel
May 8, 2021·Frontiers in Bioengineering and Biotechnology·Alex H P Chan, Ngan F Huang
May 14, 2021·APL Bioengineering·Qiao ZhangGeorge A Truskey
Jul 30, 2021·Journal of Pharmaceutical Sciences·X JosephP V Mohanan
Aug 8, 2021·International Journal of Molecular Sciences·Qingliang YangLaurie E Kilpatrick
Sep 17, 2021·Science·Adrian Roth, UNKNOWN MPS-WS Berlin 2019
Oct 15, 2021·Nature Reviews. Drug Discovery·Paul Vulto, Jos Joore
Oct 16, 2021·Journal of Cardiovascular Pharmacology·Belay Tesfamariam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.